Latest News and Press Releases

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against MP Materials Corp. f/k/a Fortress Value Acquisition Corp. (“MP Materials” or...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK) and certain...

VANCOUVER, British Columbia, March 12, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against C3.ai, Inc. (“C3.ai” or the “Company”) (NYSE: AI) and certain of its...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lexicon Pharmaceuticals, Inc. (“Lexicon” or the “Company”) (NASDAQ: LXRX).   Such...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cerence Inc. (“Cerence” or the “Company”) (NASDAQ: CRNC).   Such investors are advised to...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amryt Pharma plc (“Amryt” or the “Company”) (NASDAQ: AMYT).   Such investors are advised...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Finch Therapeutics Group, Inc. (“Finch” or the “Company”) (NASDAQ: FNCH).   Such...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (NYSE: SLI) and...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Butterfly Network, Inc. (“Butterfly” or the “Company”) f/k/a Longview...